Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Dec 3, 2024 | 12.54 | -1.49 |
Oak Valley Bancorp | OVLY | Dec 3, 2024 | 30.96 | -1.46 |
Oak Woods Acquisition | OAKU | Dec 3, 2024 | 11.26 | 0.00 |
Oaktree Acquisition III Life Sciences Unit | OACCU | Dec 3, 2024 | 10.12 | 0.00 |
Oaktree Capital A Pref | OAK-A | Dec 3, 2024 | 22.52 | +1.90 |
Oaktree Capital Group B Pref | OAK-B | Dec 3, 2024 | 22.49 | +1.26 |
Oaktree Specialty | OCSL | Dec 3, 2024 | 16.21 | -1.58 |
Oatly ADR | OTLY | Dec 3, 2024 | 0.70 | -2.23 |
Oblong | OBLG | Dec 3, 2024 | 3.40 | -2.58 |
Occidental Petroleum | OXY | Dec 3, 2024 | 50.40 | -0.04 |
Ocean Biomedical | OCEA | Dec 3, 2024 | 0.69 | -2.87 |
Ocean Power Technologies | OPTT | Dec 3, 2024 | 0.37 | -47.14 |
Oceaneering International | OII | Dec 3, 2024 | 30.42 | -0.52 |
OceanFirst Financial | OCFC | Dec 3, 2024 | 20.27 | -1.65 |
OceanFirst Pref | OCFCP | Dec 3, 2024 | 25.26 | -0.35 |
OceanPal | OP | Dec 3, 2024 | 1.43 | -1.38 |
Ocugen | OCGN | Dec 3, 2024 | 0.91 | -4.09 |
Ocular Therapeutix | OCUL | Dec 3, 2024 | 9.49 | -2.87 |
Oculis | OCS | Dec 3, 2024 | 15.37 | +0.52 |
Oddity Tech | ODD | Dec 3, 2024 | 44.84 | -0.02 |
Odyssey Marine Exploration | OMEX | Dec 3, 2024 | 0.42 | -43.63 |
Offerpad Solutions A | OPAD | Dec 3, 2024 | 5.04 | +7.69 |
Office Properties | OPI | Dec 3, 2024 | 1.58 | -1.25 |
OFG Bancorp | OFG | Dec 3, 2024 | 45.12 | -0.86 |
OFS Capital | OFS | Dec 3, 2024 | 8.22 | -0.84 |
OFS Credit | OCCI | Dec 3, 2024 | 7.30 | +0.21 |
OFS Credit C Pref | OCCIO | Dec 3, 2024 | 24.81 | -0.04 |
OFS Credit Company Pref F | OCCIM | Dec 3, 2024 | 25.00 | 0.00 |
OFS Credit E Pref | OCCIN | Dec 3, 2024 | 23.68 | -0.67 |
OGE Energy | OGE | Dec 3, 2024 | 42.83 | +0.12 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.